DUAL-ACTING THROMBOXANE RECEPTOR ANTAGONIST SYNTHASE INHIBITORS - HETEROCYCLIC VARIATIONS

被引：7
|
作者：
FAULL, AW
GASKIN, H
HADFIELD, PS
JESSUP, R
RUSSELL, K
WATKINS, WJ
WAYNE, M
机构：
[1] ICI PHARMACEUT PLC,DEPT CHEM 2,MERESIDE,ALDERLEY PK,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND
[2] ICI PHARMACEUT PLC,DEPT BIOSCI 2,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1992年 / 2卷 / 10期
关键词：
D O I：
10.1016/S0960-894X(00)80210-3
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The ability of 1,3-dioxanes bearing a variety of aromatic heterocycles at C4 to inhibit thromboxane synthase has been examined. Potent dual-acting thromboxane receptor antagonist/thromboxane synthase inhibitors have been discovered.
引用
收藏
页码：1181 / 1186
页数：6
相关论文
共 50 条
  • [31] SQ 33,961 IS A POTENT, LONG-ACTING, ORALLY ACTIVE THROMBOXANE RECEPTOR ANTAGONIST WITH WEAK THROMBOXANE A SYNTHASE INHIBITORY ACTIVITY
    OGLETREE, ML
    HARRIS, DN
    SCHUMACHER, WA
    GOLDENBERG, HJ
    MICHEL, IM
    OKEEFE, EH
    ALLEN, GT
    HERAN, CL
    STEINBACHER, TE
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1143 - 1143
  • [32] New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors
    Cimetière, B
    Dubuffet, T
    Landras, C
    Descombes, JJ
    Simonet, S
    Verbeuren, TJ
    Lavielle, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (11) : 1381 - 1386
  • [33] DESIGN OF NEW POTENTIAL 5-LIPOXYGENASE INHIBITORS, DUAL THROMBOXANE SYNTHASE INHIBITORS, AND THROMBOXANE A(2) RECEPTOR ANTAGONISTS BY AM1
    ALBUQUERQUE, MG
    RODRIGUES, CR
    DEALENCASTRO, RB
    BARREIRO, EJ
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 1995, : 181 - 190
  • [34] BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis
    Rolin, S
    Petein, M
    Tchana-Sato, V
    Dogne, JM
    Benoit, P
    Lambermont, B
    Ghuysen, A
    Kolh, P
    Masereel, B
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (01): : 59 - 65
  • [35] Dual-Acting Small-Molecule Inhibitors Targeting Mycobacterial DNA Replication
    Singh, Meenakshi
    Ilic, Stefan
    Tam, Benjamin
    Ben-Ishay, Yesmin
    Sherf, Dror
    Pappo, Doron
    Akabayov, Barak
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (47) : 10849 - 10860
  • [36] The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin
    Fontana, P.
    Alberts, P.
    Sakariassen, K. S.
    Bounameaux, H.
    Meyer, J. -P.
    Sorensen, A. Santana
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (10) : 2109 - 2111
  • [37] DUAL ANGIOTENSIN-CONVERTING ENZYME THROMBOXANE SYNTHASE INHIBITORS
    KSANDER, GM
    ERION, M
    YUAN, AM
    DIEFENBACHER, CG
    ELCHEHABI, L
    COTE, D
    LEVENS, N
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (12) : 1823 - 1832
  • [38] IN VITRO KYNURENINE MODULATION BY NOVEL DUAL-ACTING AND SELECTIVE TDO AND IDO INHIBITORS
    Alan, Wise
    Barry, Mcguinness E.
    Phillip, Cowley M.
    Sarah, Trewick C.
    Nicola, Bevan
    Clare, Szybut
    Thomas, Brown J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S5 - S5
  • [39] SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF COMBINED THROMBOXANE RECEPTOR ANTAGONIST SYNTHASE INHIBITORS - PYRIDINE-CONTAINING SULFONAMIDO ACIDS
    CAMPBELL, IB
    COLLINGTON, EW
    FINCH, H
    HAYES, R
    LUMLEY, P
    MILLS, K
    PIKE, NB
    ROBERTSON, GM
    WATTS, IS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (12) : 699 - 704
  • [40] CORRECTION OF ISCHEMIC BRAIN ACIDOSIS WITH A NOVEL THROMBOXANE RECEPTOR ANTAGONIST COMBINED WITH A THROMBOXANE SYNTHASE INHIBITOR
    PETTIGREW, LC
    HAZLE, JD
    GUTIERREZ, G
    ANNALS OF NEUROLOGY, 1990, 28 (02) : 223 - 224
12345